Av. Magalhães de Castro, 4800
240 Floor Continental Tower Building Bairro Cidade Jardim
São Paulo, SP 05676-120
Brazil
55 11 3627 4206
https://www.hyperapharma.com.br
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 10,301
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Breno Toledo Pires de Oliveira | CEO & Director | N/A | N/A | N/A |
Mr. Adalmario Ghovatto Satheler do Couto | Investor Relations Officer & CFO | N/A | N/A | N/A |
Mr. Carlos Roberto Scorsi | Chief Operating officer | N/A | N/A | 1962 |
Juliana Aguinaga Damião Salem | Senior Legal Officer & Director | N/A | N/A | N/A |
Joao Felipe Khamis Aguilar | Risks & Compliance Officer | N/A | N/A | N/A |
Mr. Luiz Eduardo Sales Clavis | VP of Sales and Marketing & Director | N/A | N/A | N/A |
Mauricio Christovam | Senior Human Resources Officer | N/A | N/A | N/A |
Mr. Hélio Segouras | Head of Consumer Health | N/A | N/A | N/A |
Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides sun protection and moisturizing skin care products under the Mantecorp Skincare brands; similar products under the Doralgina, Dropy D, balance, Flavonid, histamin, NeoFresh, neolefrin, Neochemistry Vitamins, Neosorum, and Torsilax brand names; and consumer health products under the Apracur, Benegrip, Buscopan, Coristina D Pro, Engov, Epocler, Estomazil, and Neosaldina brands, as well as similar and generic drugs under the Neo Química brand. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal brands; and generic medicines under the Hydroxyzine, Sodium Diclofenac, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 2001 and is headquartered in São Paulo, Brazil.
Hypera S.A.’s ISS governance QualityScore as of 1 May 2024 is 6. The pillar scores are Audit: 3; Board: 7; Shareholder rights: 1; Compensation: 8.